Dermatitis, Eczematous Recruiting Phase 2 Trials for Apremilast (DB05676)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03160248An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular EczemaTreatment